Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation by Ford, Mandy L. et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
ARTICLE
JEM © The Rockefeller University Press  $15.00
Vol. 204, No. 2,  February 19, 2007  299–309  www.jem.org/cgi/doi/10.1084/jem.20062319
299
Organ and cell transplantation represents an 
important means of eff  ectively treating a wide 
range of genetic and acquired diseases. A major 
challenge in transplantation is inhibiting the 
immune response mounted by the recipient 
against donor tissue. This immune attack, com-
prised of many cell types, is orchestrated by 
T cells that become activated after recognizing 
allo-antigens and receiving appropriate costim-
ulatory signals (1, 2). One promising therapy 
designed to regulate the immune response to 
donor tissue and thereby prevent the rejection 
response involves the use of reagents that block 
the costimulatory signals required for T cell 
  activation (3). The most well characterized of 
these are CD28, which is ligated by CD80 or 
CD86 (4) and can be blocked via a CTLA-4 
Ig fusion protein (4), and the CD40 pathway, 
which can be blocked using mAbs reactive against 
CD40 or CD154 (CD40L) (5).
Although very eff   ective in many experi-
mental rejection models, it is widely   recognized 
and of considerable interest that combined 
blockade of the CD28 and CD40 pathways 
does not uniformly control rejection responses, 
indicating that not all allo-reactive T cell re-
sponses are dependent on these costimulatory 
signals during primary activation. For example, 
CD28/CD154 blockade results in graft survival 
of >120 d when BALB/c skin is grafted onto 
treated C3H recipients, whereas engraftment 
of BALB/c skin onto B6 recipients treated with 
the same regimen results in only moderate 
  prolongation of graft survival (6–10). This 
breakthrough rejection could not be overcome 
simply by increasing the dose or duration 
of costimulation blockade treatment, further 
demonstrating that some T cell responses are 
fundamentally less dependent on CD28- and 
CD154-mediated costimulatory signals (7). The 
factors governing this observed relative inde-
pendence of CD28/CD154-mediated signals are 
not well understood.
In recent years, the programmed diff  erenti-
ation model has emerged as a new paradigm to 
describe T cell responses based on evidence 
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that after a brief period of antigenic stimulation, T cells 
  become committed to a program of autonomous clonal expan-
sion and diff  erentiation into eff  ector cells (11–14). T cell pro-
grams are fl  exible and can be altered by the initial priming 
conditions as well as by extrinsic factors during the execution 
of the program. Of particular relevance to transplantation 
  immunology are two recent studies indicating that the initial 
T cell precursor frequency of the responding population is a 
powerful infl  uence on the program, and that T cells that 
  undergo activation at high frequency diff  er from those that 
  become activated under conditions of low frequency in their 
ability to diff  erentiate into central and eff  ector memory 
T cells (15) and in their ability to survive as memory cells 
(16). In addition, evidence suggests that, in infection models, 
responding T cells can achieve the same clone burst size over 
a wide range of initial precursor frequencies (17, 18). In these 
instances, T cells that begin at low frequency must undergo 
many more rounds of division and hence may be more sus-
ceptible to antigen-induced cellular deletion (15, 19). Fur-
thermore, studies in models of autoimmunity have revealed 
that high initial CD8+ frequencies can convert helper-
  dependent responses into helper-independent responses (20).
Comparatively little is known about the instructional 
  developmental T cell programs that are executed during 
  allograft rejection and whether they are infl  uenced by initial 
precursor frequency. The initial frequencies of alloreactive 
T cells span a much broader range than those of pathogen-
specifi  c or autoreactive T cells. For responses across fully mis-
matched MHC disparities, up to 1 in 10–100 T cells may 
participate in the response (21), a number that is 2–3 logs 
greater than the estimated precursor frequency of pathogen-
specifi  c T cells. Although there is less quantitative informa-
tion on the frequencies of donor-reactive T cells in the setting 
of MHC-identical transplants, the frequencies are likely to be 
closer to those observed in response to pathogens (1:104–106) 
(22, 23). Varying degrees of MHC class I and II matching 
would be expected to aff  ect the initial frequency of respond-
ing CD8+ and CD4+ T cells, respectively. For this reason, 
the issue of how initial antigen-specifi  c T cell precursor fre-
quency infl  uences the kinetics, magnitude, and functionality 
of the T cell program is particularly pertinent to the fi  eld 
of transplantation.
Work from several groups has provided correlative evi-
dence that systems with low donor-reactive T cell frequency 
are more susceptible to the inhibitory eff  ects of CD28 and 
CD154 blockade than systems with high precursor frequency 
(24–26). However, direct assessment of the eff  ect of increased 
donor-reactive T cell precursor frequency has been limited 
by the availability of tools to incrementally increase both the 
donor-reactive CD4+ and CD8+ T cell compartments and 
to systematically analyze the magnitude and character of the 
responding T cell population under these conditions. In this 
study, we used a novel model in which membrane-bound 
OVA (mOVA) is constitutively expressed in all tissues under 
the control of the β-actin promoter (27). The mOVA pro-
tein contains the epitopes recognized by T cells that can be 
isolated from the TCR transgenic mice OT-I and OT-II 
(OVA 257–264/Kb and OVA 323–339/I-Ab, respectively). 
Thus, the frequency of alloreactive T cells can be manipu-
lated by titrating into naive recipients increasing numbers of 
OT-I and OT-II T cells. We therefore sought to address 
whether costimulation blockade-induced tolerance is infl  u-
enced by the precursor frequency of naive donor-reactive 
T cells. The results indicate that a critical threshold exists above 
which antigen-specifi  c T cells cannot be tolerized by CD28 
and CD154 costimulatory pathway blockade, suggesting that 
variation in the initial precursor frequencies of donor-  reactive 
CD4+ and/or CD8+ T cells is a critical determinant in the 
susceptibility or resistance to CD28/CD154 costimulation 
blockade-induced graft acceptance. We demonstrate that the 
initial frequency not only determines the fate of the graft, 
but also dictates both important quantitative and qualitative 
aspects of the developmental diff  erentiation program  executed 
by donor-specifi  c T cell populations. These results therefore 
imply that antigen-specifi  c T cell frequency during the prim-
ing phase of the immune response may infl  uence the require-
ment for CD28- and CD154-mediated costimulation during 
T cell activation and create distinct opportunities for thera-
peutic interventions.
RESULTS
Initial precursor frequency of donor-specifi  c T cells 
infl  uences division rates and acquisition of effector 
function after transplantation
To explore the eff  ects of precursor frequency on the primary 
immune response to transplanted tissues, we performed adop-
tive transfer experiments in which OVA-specifi  c OT-I 
(CD8+) and OT-II T cells (CD4+) were titrated into B6 
  recipients of mOVA skin grafts, incrementally raising the eff  ec-
tive donor-specifi   c precursor frequencies. First, we varied 
only the initial CD8+ T cell frequency and supplied a con-
stant (but elevated) frequency of CD4+ T cell help. 48 h be-
fore transplant, groups of B6 mice received either 106 or 107 
OT-I T cells. Both groups also received a fi  xed dose of 106 
OT-II CD4+ T cells. As expected, all groups rejected their 
mOVA skin grafts (not depicted). Median survival times 
(MSTs) were 20 d for mice that did not receive T cells, with 
slightly shorter survival times of 16 and 14 d for the groups 
receiving 106 and 107 OT-I T cells, respectively.
To assess the eff   ect of antigen-specifi  c  precursor  fre-
quency on the functional diff  erentiation of the responding 
T cell populations after allogeneic tissue transplantation, reci-
pients were killed at various time points after transplantation 
for analysis of the donor antigen–specifi  c T cell response. 
The transferred OT-I T cells were identifi  ed as CD8+ Thy1.1+, 
and CFSE division profi  les were examined. Division of the 
transferred populations was detectable in the draining LN 
(DLN) by day 3, with increased cell division in the low fre-
quency group (Fig. 1 A). Remarkably, by day 10 the popula-
tion that began as  10-fold lower than the high frequency 
population attained nearly identical absolute numbers in the 
DLN at the peak of the response (Fig. 1 B). Similar results JEM VOL. 204, February 19, 2007  301
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were obtained after analysis of CD8+ Thy1.1+ OT-I T cells 
isolated from the spleens of these recipients (not depicted). 
The convergence in absolute cell numbers is likely due to the 
observed increase in cell division of the low precursor fre-
quency population (Fig. 1 A), as annexin V and propidium 
iodide staining of donor-reactive CD8+ Thy1.1+ T cells did 
not suggest increased death rates in the cells stimulated at 
high frequency (not depicted). In fact, the kinetics of con-
traction of the cell populations after the peak of the response 
was more rapid in the cells stimulated at low frequency than 
in those stimulated at high frequency (Fig. 1 B). These results 
suggest that very signifi  cant diff  erences exist in terms of the 
rates of T cell expansion and contraction for T cell popula-
tions responding from low versus high precursor frequency.
To assess the eff  ect of priming at high or low precursor 
frequency on the acquisition of eff  ector function by OT-I 
T cells after antigen encounter, DLN cells from mice that 
  received 107 (high) or 106 (low) OT-I T cells were assayed 
for their ability to produce IFN-γ and TNF-α after peptide 
challenge in vitro. A higher percentage of CD8+ Thy1.1+ 
T cells stimulated under low frequency conditions produced 
IFN-γ at day 14 (55.2%) as compared with those stimulated 
at high frequency (14.5%) (Fig. 1 C). However, the total 
number of IFN-γ–producing cells per DLN was similar in 
both the high and low precursor frequency groups, suggest-
ing that cells stimulated at lower frequency reached the same 
peak number of eff  ector cells (Fig. 1 D). We also examined 
the number of OT-I cells that produced TNF-α after antigen 
rechallenge and found that although the DLNs of mice con-
taining cells stimulated at high frequency had similar numbers 
of IFN-γ– and TNF-α–secreting cells, the DLNs of mice 
containing cells stimulated at low frequency had only about 
half the number of TNF-α–producing cells as IFN-γ–
  producing cells (Fig. 1 D), suggesting a diff  erence in the quality 
of the response. Indeed, substantial evidence in the literature 
supports the idea that high quality eff  ector cells are multi-
functional in nature (28–30). Collectively, these results dem-
onstrate that although cells stimulated at high and low frequency 
are eventually suffi   cient to reject a skin graft, cell populations 
stimulated at low frequency must undergo much more extensive 
Figure 1.  OT-I T cells primed at high precursor frequency undergo 
less division and take on characteristics of higher quality effector 
cells. 106 or 107 OT-I T cells (along with 106 OT-II T cells) were adoptively 
transferred into naive B6 recipients, which then received an mOVA skin 
graft. (A) DLN OT-I T cells primed at low frequency underwent more 
rounds of division and with earlier kinetics at days 3, 7, and 14 after 
transplantation as measured by CFSE analysis. (B) Absolute numbers 
of OT-I T cells isolated from the DLN showed a convergence at the peak 
of expansion in both the low and high frequency groups. (C) Cytokine-
producing ability of cells primed at low versus high frequency was 
measured as the percentage of cells that stained positive for intracellu-
lar anti–IFN-γ after a 4-h in vitro peptide stimulation. (D) The absolute 
number of multifunctional effector cells that secreted both IFN-γ and 
TNF-α was calculated by multiplying the percentage of cytokine-positive 
cells by the total number of OT-I T cells as determined by TruCount 
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expansion to achieve this and possess fewer “high quality” 
multifunctional T cells.
CTLA-4 Ig and anti-CD154–induced tolerance can 
be overcome by increasing CD4+ and CD8+ T cell 
precursor frequencies
Based on these studies demonstrating that T cell stimulation at 
high precursor frequency resulted in less rigorous proliferation 
and more multifunctional eff  ector T cells, we hypothesized that 
high initial precursor frequency of donor-specifi  c T cells might 
also reduce the cells’ requirement for CD28- and CD154-
  mediated costimulation during primary activation. To directly 
test this, TCR transgenic OT-I and OT-II T cells were adop-
tively transferred into naive B6 recipients, incrementally raising 
the precursor frequency of antigen-specifi  c cells before engraft-
ment with mOVA skin and treatment with CTLA-4 Ig/anti-
CD154 mAbs (costimulation blockade) (Fig. 2 A). To quantify 
the “artifi  cial” precursor frequency resulting from the adoptive 
transfer of increasing numbers of antigen-specifi  c T cells, sple-
nocytes and LN cells from recipients of 105, 106, or 107 OT-I 
and OT-II T cells were analyzed for the presence of Thy1.1+ 
OT-I or OT-II T cells 48 h after transfer. Results indicated that 
the percentage of Thy1.1+ OT-I and OT-II T cells both in-
creased in a step-wise fashion, with recipients of 105 cells hav-
ing a precursor frequency of  0.04%, recipients of 106 cells 
having a frequency of  0.4%, and recipients of 107 cells having 
a frequency of  4% (Fig. 2 A). The artifi  cial precursor frequen-
cies of these adoptive transfer recipients therefore span the range 
that is thought to represent the frequencies normally observed 
for allogeneic T cell responses (21).
To assess the eff  ect of this incremental increase in precur-
sor frequency on skin graft rejection, recipients of 105, 106, or 
107 OT-I/OT-II cells were transplanted with mOVA skin 
and treated on days 0, 2, 4, and 6 with CTLA-4 Ig/anti-
CD154. Although control mice that received no T cell trans-
fer or costimulation blockade rejected their grafts with an 
MST of 21 d, mice that received costimulation blockade and 
no supplemental T cells maintained their grafts for >150 d. 
Concomitantly raising the frequency of CD4+ and CD8+ T 
cells to 0.05 or 0.5% did not aff  ect the ability of costimulation 
blockade to induce allograft tolerance; however, at antigen-
specifi  c T cell frequencies of 5% for both CD4+ and CD8+ 
compartments, mice rapidly and consistently rejected mOVA 
skin grafts despite treatment with CTLA-4 Ig/anti-CD154 
(MST 13 d; P < 0.001 as compared with all other treated 
groups) (Fig. 2 B). These results demonstrate that high anti-
gen-specifi  c T cell precursor frequency is suffi   cient to con-
vert costimulation blockade-induced allograft tolerance into 
costimulation blockade-resistant rejection due to a reduced 
requirement for CD28- and CD40L-mediated costimulatory 
signals in cells stimulated at high precursor frequency.
CD8+ OT-I T cells become “costimulation independent” 
at a lower precursor frequency than do CD4+ OT-II T cells
Next, we sought to identify the contribution of a high 
  precursor frequency of each T cell compartment to the 
  development of costimulation blockade-resistant rejection by 
independently varying the frequencies of either compartment 
before mOVA skin transplantation and CTLA-4 Ig/anti-
CD154. Results demonstrate that high frequencies of either 
subset alone were insuffi   cient to overcome the tolerizing 
  eff  ects of costimulation blockade and induce rapid and con-
sistent costimulation blockade-resistant rejection (Table I). 
Furthermore, although CD4+ T cell frequency of 0.05% was 
not suffi   cient to precipitate maximum rejection even at high 
frequencies of OT-I cells, CD4+ cell frequencies of 0.5 and 
5% both provided adequate help for 107 OT-I T cells to 
  induce maximum costimulation blockade-resistant rejection 
(Table I). Importantly, even 107 OT-II T cells were insuffi   -
cient to induce costimulation blockade-resistant rejection at 
lower frequencies of OT-I T cells (0.05 and 0.5%, or 105 and 
106 transferred cells), implicating a high precursor frequency 
of antigen-specifi  c CD8+ T cells as a major barrier to costim-
ulation blockade-induced allograft tolerance.
Precursor frequency affects susceptibility 
of the donor-specifi  c CD8+ T cell populations 
to CD28 and CD154 blockade
Given the fi  nding that a high precursor frequency of CD8+ 
T cells was critically important in the generation of costimulation 
Figure 2.  High frequency graft-specifi  c CD4+ and CD8+ T cells pre-
cipitate costimulation blockade-resistant rejection. Increasing numbers 
(105, 106, or 107) of mOVA-specifi  c OT-I and OT-II T cells were adoptively trans-
ferred into naive B6 recipients. (A) Mice were analyzed 48 h after transfer to 
determine the precursor frequency of graft-specifi  c T cells in the axillary LNs 
resulting from the transfer of each number of cells. Data are representative of 
three mice per group. (B) Recipients of the indicated numbers of graft-specifi  c 
T cells received mOVA skin grafts and CTLA-4 Ig and anti-CD154 where 
 indicated  (n = 6 mice group, two independent experiments). Results demon-
strate that raising the precursor frequency of graft-specifi  c T cells to the level 
observed in fully allogeneic situations resulted in costimulation blockade-
resistant rejection (P < 0.001 for mice receiving 107 OT-I/OT-II T cells as 
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blockade-resistant rejection, we sought to defi  ne the eff  ects of 
altered CD8+ T cell precursor frequency on the programmed 
expansion and diff  erentiation of donor-specifi  c T cells in 
the presence of costimulation blockade. Two groups of B6 
mice with varying precursor frequencies of donor-specifi  c 
CD8+ T cells were prepared by transferring 106 or 107 OT-I 
T cells. Both groups also received a fi  xed dose of 106 OT-II 
CD4+ T cells, an mOVA skin graft, and CTLA-4 Ig/anti-
CD154. Again, we observed that the initial CD8 precur-
sor frequency had a profound impact on graft survival after 
treatment with costimulation blockade. Mice that received 
106 OT-II cells and 106 OT-I T cells accepted an mOVA 
skin graft for >150 d after treatment with costimulation 
blockade, whereas mice that received 106 OT-II cells and 
107 OT-I T cells showed rapid and consistent costimula-
tion blockade-resistant rejection resulting in graft rejection 
with an MST of 17 d (P < 0.001) (Fig. 3 A). Clinical 
rejection was confi  rmed by immunohistochemical analysis 
of the donor skin tissue, which revealed Thy1.1+ infi  ltration 
at day 14 after transplant in CTLA-4 Ig/anti-CD154–treated 
mice possessing a high but not low frequency of OT-I/
OT-II T cells (Fig. S1, available at http://www.jem.org/
cgi/content/full/jem.20062319/DC1).
To assess the eff  ect of initial precursor frequency on the 
programming of the T cell response, mice were killed at vari-
ous time points after transplantation for analysis of the donor-
reactive T cell response (Fig. 3 B). Frequencies of Thy1.1+ 
CD8+ T cells in the DLN at 10 d after transplant revealed a 
marked decrease in cells primed at low but not high frequen-
cies in the presence of CTLA-4 Ig/anti-CD154. Further-
more, the absolute number of untreated CD8+ Thy1.1+ cells 
primed at low frequency increased substantially such that by 
day 10 it equaled the number of untreated CD8+ Thy1.1+ 
cells primed at high frequency (Fig. 3 C). Strikingly, cells 
primed at low frequency in the presence of costimulation 
blockade exhibited blunted expansion in total cell numbers. 
Conversely, cells stimulated at high frequency in the presence 
of costimulation blockade exhibited essentially overlapping 
magnitude and kinetics of expansion as cells from untreated 
recipients (Fig. 3 C), suggesting that blockade of CD28- and 
CD154-mediated signals has little eff  ect on the magnitude 
and kinetics of expansion of graft-specifi  c T cells primed at 
high frequency.
We also performed CFSE analysis to compare the amount 
of cell division occurring under each set of conditions. We 
observed that the more rapid division of the low frequency 
groups is dramatically stunted by costimulation blockade on 
days 3 and 7 after transplant (Fig. 4 A, top two rows). Strik-
ingly, division was less notably inhibited by costimulation 
blockade at high T cell frequency (Fig. 4 A, bottom two 
rows). Comparisons of absolute numbers of OT-I T cells that 
had undergone each number of rounds of division (0, 1, 2, 
etc.) revealed that more of the cells stimulated at low fre-
quency had divided more than fi  ve times, whereas the major-
ity of the cells stimulated at high frequency had divided fewer 
than fi  ve times (Fig. 4 B). Notably, cells stimulated at low 
frequency in the presence of CTLA-4 Ig/anti-CD154 were 
present at lower numbers in all stages of division and failed to 
accumulate in the later stages of division (more than seven 
rounds). In contrast, the division profi  le of cells stimulated at 
high frequency in the presence of costimulation blockade ex-
hibited minimal cell loss relative to untreated controls (Fig. 4 B). 
These experiments suggest that costimulation blockade quan-
titatively impacts the expansion of donor-reactive T cell 
  populations when primed under low frequency conditions, 
but has relatively little impact on cells primed under high 
  antigen-specifi  c precursor frequency conditions.
Precursor frequency qualitatively affects the phenotype 
and differentiation of donor-specifi  c T cell populations 
in response to allogeneic tissue transplantation
Based on our observations that OT-I T cells primed at low 
frequency in vivo were quantitatively susceptible to the 
  eff  ects of costimulation blockade, whereas OT-I T cells primed 
at high frequency were able to overcome the induction 
of tolerance, we hypothesized that T cells primed at high 
versus low frequency in the absence of CD28- and CD154-
mediated costimulatory signals might also be qualitatively 
  diff  erent on a per cell basis in terms of their abilities to pro-
duce the eff  ector cytokines IFN-γ and TNF-α. Although 
cells stimulated at high frequency in the presence or absence 
of costimulation blockade exhibited similar frequencies of 
Table I.  Impact of increased antigen-specifi  c CD4+ or CD8+ precursor frequencies on the requirement 
for CD28/CD154-mediated costimulation during skin graft rejectiona
Frequencyb (no. c) of CD8+ cells
Frequency (no.) 1 in 106 (None) 0.05% (105) 0.5% (106) 5% (107)
Frequency (no.) 
of CD4+ cells
1 in 106 (None) >150 d >150 >150 >150
0.05% (105) >150 >150 >150 >150
0.5% (106) >150 >150 >130.7 ± 68 17.2 ± 4.7
5% (107) >150 >150 >150 13.8 ± 1.2
aB6 mice received the indicated number of OT-I or OT-II T cells and an mOVA skin graft 48 h later. All mice were treated with CTLA-4 Ig and anti-CD154 mAbs as described in 
Materials and methods.
bResulting frequency after adoptive transfer of exogenous T cells.
cAbsolute number of adoptively transferred OT-I or OT-II T cells.
dData is expressed as the mean survival time (in days) ± SEM of 10 mice per group.304  PRECURSOR FREQUENCY IMPACTS T CELL DIFFERENTIATION | Ford et al.
IFN-γ– and TNF-α–producing cells 4 h after in vitro pep-
tide rechallenge, cells primed at low precursor frequency in 
the presence of costimulation blockade exhibited a dramati-
cally diminished ability to make IFN-γ and TNF-α as com-
pared with their untreated counterparts (Fig. 5 A and not 
depicted). The same result was observed when the total num-
ber of IFN-γ– or TNF-α–secreting cells per spleen was 
  analyzed (Fig. 5 B). This striking result closely parallels the 
observed clinical outcome of graft rejection, as mice that 
  received a low precursor frequency of OT-I T cells in the 
presence of costimulation blockade were the only group in 
which long-term tolerance was induced (Fig. 3 A).
Evidence of programming: CD8+ T cells primed at high 
or low frequency retain the imprint of these conditions 
after secondary challenge with antigen
It is becoming increasingly apparent that T cells retain an 
  imprint of their initial priming conditions, which may then 
infl  uence characteristics of the response upon subsequent 
  encounters with antigen (11–13, 31–33). To test the hypo-
thesis that precursor frequency during the priming phase of 
T cell activation is an important factor infl  uencing the T cell 
program, we established a system where OT-I T cells were 
stimulated at high or low frequency with OVA peptide in 
  vitro in the presence of CTLA-4 Ig/anti-CD154, and later 
rechallenged with an mOVA skin graft in vivo. B6 splenocytes 
were added to the low frequency in vitro cultures to keep the 
total number of cells per well constant. Consistent with our 
in vivo studies, OT-I T cells primed at low frequency in vitro 
underwent more extensive division than cells primed at high 
frequency (Fig. 6 A). 3 d later, equal numbers (5 × 106) of 
live T cells primed at an initial high or low antigen-specifi  c T 
cell frequency were adoptively transferred into P14xRAG−/− 
recipients. These mice have a T cell compartment restricted 
to the recognition of LCMV gp33-41 and therefore cannot 
reject an mOVA skin graft without the provision of exoge-
nous antigen-specifi  c T cells (unpublished data). In contrast 
to polyclonal CD4+ and CD8+ T cell populations (34 and 
unpublished data), OT-I T cells do not undergo signifi  cant 
homeostatic expansion in these hosts (unpublished data), thus 
allowing analysis of the fate and function of the adoptively 
transferred cells in this system, relatively free from the eff  ects 
of homeostatic proliferation.
48 h after T cell transfer, mice were challenged with an 
mOVA skin graft without any further CTLA-4 Ig/anti-
CD154 treatment. Naive OT-I T cells, adoptively transferred 
to an additional group as a positive control, were able to 
  reject an mOVA skin graft with an MST of 16 d (Fig. 6 B). 
Mice that received OT-I T cells primed at high or low fre-
quency in the absence of CTLA-4 Ig/anti-CD154 both rap-
idly rejected their grafts with MSTs of 14 and 15 d, 
respectively. In sharp contrast, mice receiving OT-I T cells 
stimulated in vitro at low precursor frequency in the presence 
of costimulation blockade experienced prolonged survival of 
Figure 3.  Decreased OT-I T cell expansion in the presence of 
CTLA-4 Ig/anti-CD154 after priming at low, but not high, antigen-
specifi  c precursor frequency. 106 or 107 OT-I T cells (along with 106 
OT-II cells) were adoptively transferred into naive B6 recipients that 
then received an mOVA skin graft. (A) Results showed that mice receiv-
ing a low frequency (106) of OT-I T cells were protected from rejection 
by CTLA-4 Ig/anti-CD154, whereas mice receiving a high frequency (107) 
rapidly rejected their grafts (P < 0.001). (B) Analysis of the percentage 
of Thy1.1+ CD8+ T cells in the DLN revealed that costimulation blockade 
inhibited the expansion/accumulation of OT-I T cells in mice responding 
from low frequency, whereas the expansion/accumulation of OT-I 
cells responding from high frequency was not as potently affected. 
(C) Absolute numbers of OT-I T cells isolated from the DLN showed a 
convergence at the peak of expansion at day 10 in both the low and 
high frequency untreated groups as well as the CTLA-4 Ig/anti-CD154–
treated high frequency group. In contrast, the low frequency, CTLA-4
Ig/anti-CD154–treated group exhibited minimal expansion of OT-I 
T cell numbers. These data are representative examples of four inde-
pendent experiments, with two to three mice per group, per time point, 
per experiment.JEM VOL. 204, February 19, 2007  305
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their mOVA skin grafts (MST >40 d; P < 0.001 when com-
pared with all other groups), whereas mice receiving an equal 
number of T cells that had been primed under high frequency 
conditions in the presence of costimulation blockade rapidly 
and consistently rejected their grafts with an MST of 16 d 
(Fig. 6 B). Analysis of the peripheral blood of these mice 40 d 
after transfer indicated that this outcome was not due to a 
failure of the cells primed at low frequency to survive after 
transfer, as comparable numbers of CD8+ Thy1.1+ cells were 
present in the two groups (Fig. 6 C). Because both cell types 
were present at equal frequencies during secondary antigenic 
challenge, these results suggest that the low initial precursor 
frequency and absence of costimulation during the priming 
phase of the immune response programmed the formation 
of functionally inactive eff  ector cells that were incapable of 
rejecting a skin graft.
DISCUSSION
The use of tools to track the fate and function of antigen-
specifi  c T cells in experimental models of pathogen infection 
has supplied critical quantitative information that defi  ned the 
working paradigm that, after initial encounter with antigen, 
T cells execute a programmed response that is imprinted dur-
ing primary activation and includes expansion, death, and 
maintenance phases (13, 31, 35). Recent studies in other 
models have revealed how the initial precursor frequency can 
dictate the phenotypic and functional outcome of the T cell 
response to a pathogen (15, 23), and can infl  uence cell sur-
vival and memory cell formation after immunization (16). 
Figure 4.  OT-I T cells primed at low frequency in the presence 
of CTLA-4 Ig and anti-CD154 fail to accumulate in later rounds 
of cell division. 106 or 107 OT-I T cells (along with 106 OT-II cells) were CFSE 
labeled and adoptively transferred into naive B6 recipients, which then 
received an mOVA skin graft. (A) Analysis of Thy1.1+ CD8+ DLN cells dem-
onstrated reduced rounds of cell division in OT-I T cells responding from 
low frequency in the presence of CTLA-4 Ig/anti-CD154 relative to those 
left untreated (top two rows). In contrast, the cell division profi  le of OT-I 
cells responding from high frequency was not as potently affected by 
costimulation blockade (bottom two rows). (B) Absolute numbers of DLN 
OT-I T cells in each cell generation (0, no cell division) were calculated 
from the percentage of each population in peaks 0–7 or >7 (generation 8+). 
Data show that CTLA-4 Ig/anti-CD154–treated graft-specific cells 
  responding from high frequency exhibited a division profi  le similar to 
those in the untreated controls, whereas cells responding from low fre-
quency divided but failed to accumulate in the presence of CTLA-4 
Ig/anti-CD154. These data are representative examples of four independent 
experiments, with two to three mice per group per experiment.
Figure 5.  Reduced numbers of functional effector cells in CTLA-4 
Ig– and anti-CD154–treated mice with low precursor frequency of 
graft-specifi  c cells. 106 or 107 OT-I T cells (along with 106 OT-II cells) 
were adoptively transferred into naive B6 recipients before transplanta-
tion with an mOVA skin graft. (A) IFN-γ production by cells primed at 
low versus high frequency in the presence or absence of CTLA-4 Ig/
anti-CD154 was measured as the percentage of Thy1.1+ CD8+ T cells that 
stained positive for intracellular anti–IFN-γ after a 4-h in vitro peptide 
stimulation. (B) The absolute number of cytokine-producing effector cells 
that secreted IFN-γ or TNF-α was calculated by multiplying the percent-
age of cytokine-positive cells by the total number of OT-I T cells as deter-
mined by TruCount analysis. Results indicate that both the percentage 
(A and not depicted) and absolute numbers (B) of IFN-γ– and TNF-α–secre-
ting cells were diminished in mice primed at low but not high frequency 
in the presence of CTLA-4 Ig/anti-CD154. These data are representative 
examples of four independent experiments, with two to three mice per 
group per experiment.306  PRECURSOR FREQUENCY IMPACTS T CELL DIFFERENTIATION | Ford et al.
In contrast to the wealth of information on protective responses 
against pathogens, because of a lack of tools, relatively little is 
known about the programming of donor-specifi  c T cells in 
response to an allograft. Although some pioneering work 
has been done with transgenic mice in transplant models 
(27, 36–38), to date there have not been systematic studies track-
ing the programmed response of both donor-specifi  c CD4+ 
and CD8+ populations during rejection responses starting 
across the range of precursor frequencies that approximate 
the spectrum of frequencies that have been measured for allo-
immune responses. Here, we demonstrate very profound dif-
ferences in the T cell response to allografted tissue depending 
on the initial T cell frequencies. Specifi  cally, we found that 
cells that were stimulated at low frequency exhibited higher 
and more rapid rates of replication (Fig. 1 A) and poor multi-
functional cytokine production (Fig. 1 D). At the other end 
of the spectrum, the transfer of higher numbers of CD8+ 
(107) donor-specifi  c T cells resulted in similar peak absolute 
numbers of CD8+ T cells after transplantation, but the cells 
had undergone fewer divisions on a per cell basis and showed 
a much higher frequency of CD8+ T cells with multi-
  cytokine production capacity (Fig. 1). From these fi  ndings, 
we conclude that initial antigen-specifi  c T cell precursor 
  frequency critically impacts the character of the primary 
  immune response to allogeneic tissue transplantation. A recent 
seminal study by Marzo et al. (15) demonstrated that T cells 
primed at high frequency are more likely to diff  erentiate into 
central memory T cells than those primed at low frequency, 
showing that precursor frequency can infl  uence the character 
of CD8+ T cell memory. Hataye et al. (16) found that clonal 
frequency infl  uenced T cell survival and degree of memory 
cell formation. However, initial antigen-specifi  c T cell fre-
quency is just beginning to be appreciated as an important 
cell-extrinsic factor governing the antigen-specifi   c T cell 
program. Here, we demonstrate for the fi  rst time that initial 
T cell precursor frequency critically impacts the functional 
character of the primary immune response as well.
We also addressed the eff  ect of initial T cell frequency on 
the requirement for CD28/CD154-mediated costimulatory 
signals during immune activation. The results of our studies 
reveal a signifi  cant negative eff  ect of CTLA-4 Ig and anti-
CD154 on the proliferative burst size and eff  ector function of 
cells stimulated at low frequency (Fig. 3). Analysis of absolute 
numbers of donor-reactive T cells that had undergone 0, 1, 2, 
etc. rounds of divisions revealed that CD28/CD154 block-
ade did not inhibit cells from entering cycle; rather, it   resulted 
in abortive proliferation, failure of cells that had divided 
more than fi  ve times to accumulate as early as 7 d after trans-
plantation (Fig. 4 B), and a dramatic decrease in the number 
of cytokine-producing eff  ector cells (Fig. 5). The persistence 
of antigen-specifi  c but functionally ineff  ective T cells is a 
phenotype reminiscent of the state of anergy originally 
  described by Schwartz (39), but with some important diff  er-
ences. Although anergy is defi  ned as diminished proliferation 
and IL-2 production after antigenic rechallenge with the rel-
ative sparing of eff   ector cytokine secretion (IFN-γ/IL-4) 
(39), we observed abortive proliferation and a dramatic inhi-
bition of IFN-γ and TNF-α secretion after in vitro   rechallenge 
Figure 6.  CD8+ T cells stimulated at initial high or low frequency 
retain the imprint of the conditions under which they were primed 
after secondary antigenic challenge. OT-I T cells were CFSE labeled and 
stimulated with OVA peptide at high (3 × 106 cells/well) or low frequency 
(3 × 105 cells/well) in the presence of 100 μg/ml CTLA-4 Ig/anti-CD154. 
B6 splenocytes were added to the low frequency cultures to keep the 
total number of cells per well consistent. (A) 3 d later, CFSE dilution of live 
CD8+ Thy1.1+ cells was measured by fl  ow cytometry. Cells stimulated at 
low frequency underwent more rounds of division than those primed at 
high frequency, and CTLA-4 Ig/anti-CD154 did not inhibit cell division in 
the 72-h culture period (data shown are representative examples from 
three independent experiments). (B) 5 × 106 T cells from cultures primed 
at an initial high or low antigen-specifi  c T cell frequency were adoptively 
transferred into P14xRAG−/− recipients. Mice received an mOVA skin 
graft 48 h later and were monitored for signs of rejection (data shown 
are cumulative results from three independent experiments, with the 
total number of mice indicated in the legend). (C) Analysis of peripheral 
blood of recipients of cells stimulated in vitro at low or high frequency 
at day 40 after transplantation revealed similar frequencies of CD8+ 
Thy1.1+ cells.JEM VOL. 204, February 19, 2007  307
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of cells stimulated at low frequency in the presence of co-
stimulation blockade. This phenotype may be more closely 
related to that observed in exhausted T cells in models of 
chronic viral infection (35). In contrast, our data reveal that 
at initial high frequency, costimulation blockade had a very 
limited impact on the magnitude of the response, CFSE 
  division profi  le, and acquisition of eff  ector function of graft-
specifi  c CD8+ T cells (Figs. 3 and 4). Based on these results, 
we conclude that high initial precursor frequency of antigen-
specifi  c CD8+ T cells can obviate the need for CD28/
CD154-mediated costimulatory molecules and is a powerful 
determinant of the susceptibility or resistance to costimula-
tion blockade-induced graft acceptance. Although it is com-
monplace for high frequencies of cells to be used in in vivo 
adoptive transfer experiments investigating the eff  ects of 
  costimulation on primary T cell responses to facilitate their 
identifi  cation and analysis (15, 40, 41), our fi  ndings suggest 
that experimental design should take into account the pre-
cursor frequency appropriate for the model being studied.
Although our study demonstrated that one of the critical 
factors impacting CD8+ T cell requirement for CD28- 
and CD40L-mediated costimulatory signals during primary 
  immune activation is initial precursor frequency, the precise 
mechanism of this phenomenon remains to be determined. 
Our results demonstrate that a hallmark characteristic of 
  costimulation-independent cells primed at high frequency is 
that they undergo fewer cell divisions after antigen encounter 
than those primed at lower cell frequency. We speculate that 
this increase is due to reduced competition for antigen or 
  access to APCs among the antigen-specifi  c T cells, as has been 
demonstrated for CD4+ T cells (42), and that reduced com-
petition manifests as a stronger antigenic stimulus. A lack 
of costimulatory signals during T cell priming in cells that 
  receive this stronger stimulus and thus are programmed to 
  divide many times may be a catastrophic event. In this way, 
cells may calibrate the amount of costimulation they require 
against the amount they receive, and in the absence of suffi   -
cient costimulation, cells may fail to accumulate at later 
rounds of division and to diff  erentiate into competent eff  ec-
tor cells.
An alternate, but not mutually exclusive, possibility that 
may explain the relative costimulation independence of 
T cells stimulated at high frequency is that the number of 
T cells on a given APC may aff  ect the outcome of the T cell 
response. It is possible that the low amounts of soluble factors 
such as IL-2 that are secreted even in the presence of CTLA-
4 Ig/anti-CD154 are suffi   cient to provide external growth 
signals when produced by many cells in the same microenvi-
ronment. Alternatively, the presence of many T cells on a 
single APC may lead to increased or diff  erential activation of 
the APC, such that it is now better able to stimulate the 
  responding T cells. Such changes could include increased ex-
pression of costimulatory molecules other than CD80/CD86 
and CD40, such that costimulation is provided by molecules 
other than the ones blocked in our study. Increased frequency 
of antigen-specifi  c T cells within the LN environment could 
also increase the likelihood of these cells interacting with 
nontraditional APCs that express costimulatory molecules 
other than CD80, CD86, and CD40.
The fact that the number of competent eff  ector  cells 
reaches a similar apex in mice that reject their grafts, regard-
less of initial precursor frequency, indicates that some critical 
threshold exists for the successful rejection of an allogeneic 
skin graft. Studies by Jones et al. (36) have provided addi-
tional evidence that T cell–mediated allograft rejection re-
quires the generation of a critical threshold of diff  erentiated 
eff  ector T cells. Interestingly, this rejection threshold is spe-
cifi  c to the allograft type, with larger numbers of eff  ectors 
being required for the rejection of heart as compared with 
skin or islet allografts (36); therefore, diff  erences in the initial 
precursor frequency of donor-specifi  c CD8+ and/or CD4+ 
T cells may result in distinct eff  ects on graft survival and the 
character and magnitude of the T cell program elicited by 
diff  erent allograft types. Certainly, the signals and feedback 
loops used by the immune system to determine the critical 
number of cells needed to reject a particular graft are  unknown 
and represent new areas for study that may result in novel 
targets for therapeutic intervention.
The studies described here have important potential 
clinical implications. As new costimulation blockade-based 
modalities enter clinical trials in transplantation, it will be 
important to understand the circumstances that predict a 
greater likelihood of success or portend breakthrough rejec-
tion, such as high initial CD8+ T cell frequency. If initial 
precursor frequency also proves to have a powerful eff  ect in 
human allo-specifi  c T cell responses, this knowledge could 
be used to prompt consideration of alternative approaches to 
organ allocation, for example, reemphasizing class I match-
ing as a means to eff  ectively lower the graft-specifi  c CD8+ 
T cell frequency. More likely, knowledge of low CD8+ 
donor-reactive precursor frequency in a particular patient 
could be used to direct the reduction of immunosuppression 
or prompt attempts at tolerance induction, whereas detection 
of high frequencies could direct the intensifi  cation of immuno-
suppression for the control of breakthrough CD8+ T cell 
responses. In addition, our studies predict that   costimulatory 
blockade may synergize with agents designed to reduce the 
initial frequency of all T cells, such as anti-CD52 (43, 44) 
or anti-CD3 mAbs (45), in that these agents would eff  ec-
tively lower the initial frequency of graft-specifi  c T cells 
and thereby increase the effi   cacy of treatment with costimu-
latory blockade.
MATERIALS AND METHODS
Mice. 6–8-wk-old adult male C57BL/6 mice were purchased from The Jackson 
Laboratory. TCR transgenic OT-I and OT-II mice were purchased from 
  Taconic, Inc. and bred onto RAG−/− and Thy1.1+ backgrounds. Act-mOVA 
mice were provided by M. Jenkins (University of Minnesota, Minneapolis, 
MN). Animals received humane care and treatment in accordance with Emory 
University Institutional Animal Care and Use Committee guidelines.
Skin grafting and costimulation blockade. Full thickness dorsal ear and 
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mice and secured with a plastic adhesive bandage for 5 d. Graft survival was 
monitored by daily visual inspection. Rejection was defi  ned as the complete 
loss of viable epidermal tissue. Where indicated, recipients of skin grafts 
  received treatment with 500 μg each of hamster anti–mouse CD154 mAb 
(MR-1; Bioexpress) and human CTLA-4 Ig (Bristol-Meyers Squibb) ad-
ministered i.p. on the day of transplantation (day 0) as well as after transplant 
on days 2, 4, and 6.
T cell adoptive transfers. OT-I and OT-II TCR transgenic T cells 
were harvested from the spleens of OT-IxThy1.1+xRAG−/− and OT-
IIxThy1.1+xRAG−/− mice, respectively. Single cell suspensions were pre-
pared and counted, and the frequency of OT-I or OT-II T cells within the 
splenocyte preparation was determined before adoptive transfer by staining 
with anti-Vα2 (used by both TCRs) and anti-CD8 or anti-CD4, respec-
tively (BD Biosciences). Cells were labeled with 5 μM CFSE before adop-
tive transfer. Mice received a single i.v. injection of the indicated number of 
OT-I or OT-II T cells along with syngeneic B6 carrier splenocytes.
Flow cytometric analyses for frequency and absolute number. At the 
indicated time points, recipients of OT-I and/or OT-II T cell transfers were 
killed, spleens and draining axillary LNs were harvested, and single cell sus-
pensions were prepared. Cells were stained with Thy1.1-PerCP, CD8-
  PacOrange, and CD4-PacBlue (all BD Biosciences) for fl  ow  cytometric 
analysis on a BD LSRII multicolor fl  ow cytometer. In some cases, the abso-
lute number of antigen-specifi  c T cells was determined by TruCount Bead 
Analysis (BD Biosciences) according to the manufacturer’s instructions. Flow 
cytometric data were analyzed using FlowJo Software (Treestar).
Intracellular cytokine staining. For measurement of IFN-γ– and TNF-
α–secreting cells, single cell suspensions of splenocytes or draining axillary 
LN cells from adoptive transfer/skin graft recipients (106 per well) were 
  incubated in a 96-well plate with 10 μM OVA257–264 (SIINFEKL; Emory 
University Microchemical Core Facility) and 10 μg/ml brefeldin A (BD 
Biosciences). After 6 h in culture, cells were processed using an intracellular 
staining kit (BD Biosciences) according to the manufacturer’s instruc-
tions and stained with anti–TNF-α–PE, anti–IFN-γ–APC, anti–Thy1.1-
PerCP, anti-CD8–Pacifi  c Orange, and anti-CD4–Pacifi  c Blue (all from 
BD Biosciences).
In vitro T cell stimulation, separation, and adoptive transfer. OT-I 
T cells were stimulated with OVA peptide at high (3 × 106 cells/well) or 
low frequency (3 × 105 cells/well) in a 24-well plate in the presence of 
100 μg/ml CTLA-4 Ig and anti-CD154. B6 splenocytes were added to the 
low frequency cultures to keep the total number of cells per well consistent. 
Culture media consisted of RPMI 1640 supplemented with 10% FBS 
  (Mediatech), 2 mM l-glutamine, 0.01 M Hepes buff  er, 100 μg/ml genta-
mycin (Mediatech), and 5 × 10−5 M 2-mercaptoethanol (Sigma-Aldrich). 
3 d later, live cells were isolated by Ficoll-Hypaque centrifugation (Mediatech) 
and 5 × 106 T cells from cultures primed at an initial high or low antigen-
specifi  c T cell frequency were adoptively transferred into P14xRAG−/− 
  recipients as described above.
Statistical analyses. Skin graft rejection is represented by Kaplan-Meier 
survival curves. Statistical comparisons of mean survival times were per-
formed using nonparametric one-way ANOVA (Kruskal-Wallis test), fol-
lowed by Dunn’s multiple comparisons posttest comparing the relevant 
datasets (GraphPad Prism Software).
Online supplemental material. Fig. S1 shows donor skin graft tissue 
that was harvested on day 14 after transplant, and 100% acetone-fi  xed tis-
sue was frozen in OCT compound (Tissue-Tek) to test for the presence of 
Thy1.1+ OT-I/OT-II T cell infi  ltrates. Frozen tissue sections were coun-
terstained with hematoxylin, labeled with biotinylated anti-Thy1.1, and 
visualized using the Dako LSAB + labeled streptavidin-HRP kit. Tissue sec-
tions from three mice per group (representative samples are shown)   revealed 
the presence of Thy1.1+ cells in both groups receiving no treatment (both 
left panels) and the mice receiving a high frequency of OT-I T cells with 
CTLA-4 Ig/anti-CD154 (bottom right). No Thy1.1+ cells were detect-
able in the tissue of mice receiving a low frequency of OT-I T cells and 
CTLA-4 Ig/anti-CD154 (top right). Fig. S1 is available at http://www.jem
.org/cgi/content/full/jem.20062319/DC1.
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